BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 200244)

  • 21. Relationships between thyroid hormone and glucocorticoid effects in GH3 pituitary cells.
    Perrone MH; Greer TL; Hinkle PM
    Endocrinology; 1980 Feb; 106(2):600-5. PubMed ID: 6243541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid hormone controls glucocorticoid action in cultured GH1 cells.
    Samuels HH; Horwitz ZD; Stanley F; Casanova J; Shapiro LE
    Nature; 1977 Jul; 268(5617):254-7. PubMed ID: 196206
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of calcium in the thyrotropin-releasing hormone-stimulated release of prolactin from pituitary cells in culture.
    Tashjian AH; Lomedico ME; Maina D
    Biochem Biophys Res Commun; 1978 Apr; 81(3):798-806. PubMed ID: 96826
    [No Abstract]   [Full Text] [Related]  

  • 24. Bihormonal regulation of the thyrotropin-releasing hormone receptor in mouse pituitary thyrotropic tumor cells in culture.
    Gershengorn MC
    J Clin Invest; 1978 Nov; 62(5):937-43. PubMed ID: 213447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radio-receptor assay for thyrotropin releasing hormone (author's transl)].
    Faivre-Bauman A; Gourdji D; Tixier-Vidal A
    Ann Endocrinol (Paris); 1977; 38(4):265-71. PubMed ID: 197873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of a heterogenous population of binding sites for thyroliberin in prolactin-producing tumour cells and their possible functional significance.
    Gautvik KM; Lystad E
    Eur J Biochem; 1981 May; 116(2):235-42. PubMed ID: 6265214
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological and biochemical comparison of thyrotropin releasing hormone (TRH) and di-methyl proline-TRH on pituitary GH3 cells.
    McDermott AM; Wilkin GP; Dickinson SL
    Br J Pharmacol; 1990 Nov; 101(3):615-20. PubMed ID: 1963801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solubilization of pituitary receptors for thyrotropin-releasing hormone.
    Hinkle PM; Lewis DG
    Biochim Biophys Acta; 1978 Jul; 541(3):347-59. PubMed ID: 208640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of lipids in gonadotropin releasing hormone agonists and antagonist binding to rat pituitary.
    Hazum E; Garritsen A; Keinan D
    Biochem Biophys Res Commun; 1982 Mar; 105(1):8-13. PubMed ID: 6284152
    [No Abstract]   [Full Text] [Related]  

  • 30. Degradation of thyrotropin-releasing hormone by the GH3 strain of pituitary cells in culture.
    Hinkle PM; Tashjian AH
    Endocrinology; 1975 Aug; 97(2):324-31. PubMed ID: 169122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain TRH receptors are the same as pituitary TRH receptors.
    Detimar PW; Lynn AG; Metcalf G; Morgan BA
    J Pharm Pharmacol; 1983 Jun; 35(6):399-400. PubMed ID: 6135787
    [No Abstract]   [Full Text] [Related]  

  • 32. Thyrotropin-releasing hormone activates a [Ca2+]i-dependent K+ current in GH3 pituitary cells via Ins(1,4,5)P3-sensitive and Ins(1,4,5)P3-insensitive mechanisms.
    Mollard P; Dufy B; Vacher P; Barker JL; Schlegel W
    Biochem J; 1990 Jun; 268(2):345-52. PubMed ID: 2163608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fate of thyrotropin releasing hormone after binding and stimulation of prolactin release by GH3 cells. Evidence for release of unmodified (3H)-TRH.
    Gourdji D; Tixier-Vidal A; Levine-Pinto H; Pradelles P; Morgat JL; Fromageot P
    Neuroendocrinology; 1976; 20(3):201-11. PubMed ID: 822368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solubilization of receptors for thyrotropin-releasing hormone from GH4C1 rat pituitary cells: demonstration of guanyl nucleotide sensitivity.
    Sullivan NJ; Lautens LL; Tashjian AH
    Mol Endocrinol; 1987 Dec; 1(12):889-98. PubMed ID: 2856405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyrotropin-releasing hormone modulation of uridine uptake in rat pituitary cells. Characterization of the responses.
    Martin TF; Cort AM; Tashjian AH
    J Biol Chem; 1978 Jan; 253(1):99-105. PubMed ID: 201625
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fate of thyrotropin releasing hormone after binding to rat prolactin secreting cells (GH3 line). Evidence for releasing of unmodified [3H]-TRH (author'r transl)].
    Gourdji D; Tixier-Vidal A; Levine-Pinto H; Pradelles PH; Morgat JL; Fromageot P
    Ann Endocrinol (Paris); 1976; 37(2):119-20. PubMed ID: 827233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of thyrotropin receptor from thyroid plasma membranes: effect of hydrocortisone, propranolol, and adenosine 3',5'-monophosphate.
    Hashizume K; DeGroot LJ
    Endocrinology; 1980 May; 106(5):1463-8. PubMed ID: 6244931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes of pituitary thyrotropin releasing hormone (TRH) receptor level and prolactin response to TRH during the rat estrous cycle.
    Léan AD; Garon M; Kelly PA; Labrie F
    Endocrinology; 1977 Jun; 100(6):1505-10. PubMed ID: 192538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological activities of thionated thyrotropin-releasing hormone analogs.
    Lankiewicz L; Bowers CY; Reynolds GA; Labroo V; Cohen LA; Vonhof S; Sirén AL; Spatola AF
    Biochem Biophys Res Commun; 1992 Apr; 184(1):359-66. PubMed ID: 1314591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, receptor binding affinities and alpha-MSH releasing activities of TRH analogues.
    Aleksandrova M; Przybylski J; Kruszyński M; Tonon MC; Vaudry H; Zboińska J; Kupryszewski G
    Pol J Pharmacol Pharm; 1985; 37(2):197-207. PubMed ID: 2995954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.